Arrowhead Pharmaceuticals, Inc. Financial Ratios — ARWR

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-22.16	-130.34	-115.65	-53.26	-58.36	-62.76	-29.61	-50.5	29.46	-19.39	-22.85	-25.11	-28.17	-62.93	-0.13
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-15.02	- -	- -	- -	- -	- -	-1.62
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	35.73	- -	- -	- -	- -	- -	7.31
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-3,228.99	-13,167.82	-7,417.27	-28,433.28	-24,512.5	-48,272.86	-102.86	-317.41	38.88	-99.12	-101.79	-69.11	-79.97	-16,403.41	14.74
Operating Margin (%)	-3,319.48	-14,358.61	-8,020.65	-29,202.23	-25,124.08	-50,331.84	-117.79	-346.52	36.25	-105.87	-107.77	-73.39	-85.16	-16,927.06	11.86
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	76.73	- -	- -	- -	- -	- -	84.69
Pretax Margin (%)	-2,966.52	-15,054.05	-10,922.08	-33,554.35	-24,067.67	-51,613.12	-109.46	-337.3	40.37	-96.09	-101.85	-71.01	-85.78	-17,247.54	6.21
Profit Margin (%)	-1,056.56	-14,383.61	-10,729.22	-33,502.97	-24,068.29	-51,614.64	-109.46	-337.32	40.27	-96.09	-101.85	-72.39	-85.27	-16,882.37	-0.2
Net Income to Common Margin (%)	-1,056.56	-14,383.61	-10,729.22	-33,502.97	-24,068.29	-51,614.64	-109.46	-337.32	40.27	-96.09	-101.85	-72.39	-85.27	-16,882.37	-0.2
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	0.26	- -	- -	- -	- -	- -	41.56
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	1	2	2	1	1	3	3	2	- -	21	26	82	115	511	366
ST Debt	- -	- -	1	- -	- -	- -	- -	- -	- -	1	2	3	11	6	47
LT Debt	1	2	1	1	1	3	2	2	- -	20	23	79	105	504	319
Total Debt/EBITDA	-0.06	-0.13	-0.11	-0.02	-0.01	-0.04	-0.08	-0.05	- -	-0.24	-0.18	-0.49	-0.6	-0.88	3
Net Debt/EBITDA	0.72	0.13	0.84	2.66	0.87	1.08	0.69	0.54	-3.38	1.65	1.31	0.64	0.58	-0.54	1.36
Total Debt/EBIT	-0.06	-0.12	-0.1	-0.02	-0.01	-0.03	-0.07	-0.04	- -	-0.23	-0.17	-0.46	-0.56	-0.85	3.72
Net Debt/EBIT	0.7	0.12	0.78	2.59	0.85	1.04	0.6	0.5	-3.62	1.54	1.24	0.61	0.54	-0.53	1.69
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-10.5	-18	1.37
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-20.15	-22.38	1.11
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-11.19	-18.58	1.1
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	18	32	89
Common Equity/Total Assets	-716.15	-816.14	-444.73	-122.87	-239.33	-310.72	-415.92	-436.42	-119.8	-96.39	-90.76	-118.59	-134	-142.6	-117.44
Long-Term Debt/Equity (%)	4.83	24.09	4.32	0.46	0.49	2.67	2.88	2.21	- -	4.34	5.7	18.84	36.43	263.9	63.37
Long-Term Debt/Capital (%)	-0.54	-1.59	-0.67	-0.34	-0.17	-0.64	-0.54	-0.43	- -	-4.15	-3.76	-10.96	-11.69	-45.46	-26.08
Long-Term Debt/Total Assets (%)	3.82	12.84	2.98	0.41	0.41	1.98	2.24	1.88	- -	3.84	3.28	11.39	13.66	44.24	23.03
Total Debt/Equity (%)	4.83	27.66	8.95	0.62	0.69	2.87	3.13	2.44	- -	4.58	6.25	19.5	40.11	267.22	72.76
Total Debt/Capital (%)	-0.54	-1.82	-1.39	-0.46	-0.24	-0.69	-0.59	-0.48	- -	-4.38	-4.13	-11.34	-12.87	-46.03	-29.94
Total Debt/Total Assets (%)	3.82	14.74	6.17	0.56	0.57	2.13	2.44	2.08	- -	4.05	3.6	11.79	15.04	44.79	26.44
Net Debt to Equity	-54.92	-27.68	-70.31	-79.8	-74.09	-86.97	-27.58	-29.2	-90.89	-31.09	-45.11	-25.82	-38.62	165.9	33.01
Net Debt/Capital (%)	5.71	1.78	9.8	37.14	20.43	17.16	4.9	5.39	34.58	22.93	22.96	13.06	11.03	-26.74	-12.67
EBITDA	-10	-19	-22	-50	-94	-76	-32	-51	66	-87	-141	-168	-193	-582	122
EBITDA-CapEx	-10	-20	-22	-51	-96	-80	-40	-53	54	-99	-164	-221	-369	-724	100
Operating Income (Loss)	-10	-21	-23	-51	-96	-80	-37	-56	61	-93	-149	-179	-205	-601	98

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.15	0.65	3.23	13.01	6.21	3.33	3.51	6.19	2.67	7.76	2.51	2.71	3.83	6.6	4.7
Current Ratio	3.82	1.23	3.31	13.07	6.47	3.53	3.63	6.37	2.73	7.92	2.62	2.92	3.95	6.74	4.86
Quick Ratio	3.78	1.12	3.23	13.01	6.21	3.33	3.51	6.22	2.67	7.78	2.58	2.72	3.83	6.6	4.74
CFO/Avg Current Liab	-1.57	-3.88	-2.71	-3.44	-4.74	-3.1	-1.08	-3.04	3.16	-1.39	1.83	-0.95	-1.26	-4.44	1.2
Common Equity/Total Assets	-716.15	-816.14	-444.73	-122.87	-239.33	-310.72	-415.92	-436.42	-119.8	-96.39	-90.76	-118.59	-134	-142.6	-117.44
Long-Term Debt/Equity (%)	4.83	24.09	4.32	0.46	0.49	2.67	2.88	2.21	- -	4.34	5.7	18.84	36.43	263.9	63.37
Long-Term Debt/Capital (%)	-0.54	-1.59	-0.67	-0.34	-0.17	-0.64	-0.54	-0.43	- -	-4.15	-3.76	-10.96	-11.69	-45.46	-26.08
Long-Term Debt/Total Assets (%)	3.82	12.84	2.98	0.41	0.41	1.98	2.24	1.88	- -	3.84	3.28	11.39	13.66	44.24	23.03
Total Debt/Equity (%)	4.83	27.66	8.95	0.62	0.69	2.87	3.13	2.44	- -	4.58	6.25	19.5	40.11	267.22	72.76
Total Debt/Capital (%)	-0.54	-1.82	-1.39	-0.46	-0.24	-0.69	-0.59	-0.48	- -	-4.38	-4.13	-11.34	-12.87	-46.03	-29.94
Total Debt/Total Assets (%)	3.82	14.74	6.17	0.56	0.57	2.13	2.44	2.08	- -	4.05	3.6	11.79	15.04	44.79	26.44
CFO/Total Liabilities	-162.16	-198.74	-164.15	-210.42	-290.15	-194.34	-103.39	-288.49	163.53	-157.76	56.85	-49.76	-32.17	-48.79	20.36
CFO/CapEx	-557.24	-31.98	-64.11	-20.62	-33.34	-16.69	-3.02	-33.23	14.42	-8.02	7.27	-2.58	-0.87	-3.27	7.92
Altman's Z-Score	-7.87	-19.61	-1.29	23	2.65	1.11	0.66	50.47	14.95	41.7	11.5	5.95	1.63	-1.67	2.98

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	0.36	0.18	6.88	4.67	- -	4.22	439.89	81.7	341.44	116.75	24.91	41.7	341.47	- -	243.1
Days Sales Outstanding	1,027.46	2,010.15	53.05	78.21	- -	86.45	0.83	4.47	1.07	3.13	14.65	8.75	1.07	- -	1.5
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	28	29	137	693	330	449	320	1,603	2,645	4,337	6,477	3,502	2,883	2,320	4,613
- Cash & Cash Equivalents	8	3	19	133	81	85	25	30	222	144	184	108	111	76	89
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	-1	-2	-1	-1	-1	-1	-1	-1	- -	- -	20	16	6	37
+ Total Debt	1	2	2	1	1	3	3	2	- -	21	26	82	115	511	366
Enterprise Value	20	27	109	540	232	366	256	1,529	2,386	4,043	6,135	3,227	2,611	2,155	4,098
Total Capital	-113	-134	-165	-224	-316	-396	-431	-485	-420	-483	-619	-719	-895	-1,109	-1,223
Total Debt/Capital (%)	-0.54	-1.82	-1.39	-0.46	-0.24	-0.69	-0.59	-0.48	- -	-4.38	-4.13	-11.34	-12.87	-46.03	-29.94
Total Debt / EV	0.03	0.09	0.02	- -	- -	0.01	0.01	- -	- -	0.01	- -	0.03	0.04	0.24	0.09
EV/Sales	68.24	183.21	375.41	3,082.88	606.89	2,308.62	8.16	94.69	14.13	45.94	44.36	13.27	10.85	606.99	4.94
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	36.35	- -	- -	- -	- -	- -	33.51
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	38.99	- -	- -	- -	- -	- -	41.67
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	13.79	- -	35.81	- -	- -	- -	17.68
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	12.89	- -	31.48	- -	63.03	- -	16.1
Diluted Market Cap	28	29	137	693	330	449	320	1,603	2,779	4,337	6,477	3,502	2,883	2,320	4,613
Diluted Enterprise Value	21	27	118	561	249	366	297	1,575	2,556	4,215	6,318	3,495	2,904	2,760	4,928
EV per Share	2.81	2.42	4.54	11.5	4.04	5.99	3.47	18.28	25.42	40.14	59.13	30.45	24.33	17.99	30.63
TTM Sales	- -	- -	- -	- -	- -	- -	31	16	169	88	138	243	241	4	829
TTM EBITDA	-10	-19	-22	-50	-94	-76	-32	-51	66	-87	-141	-168	-193	-582	122
TTM Operating Income	-10	-21	-23	-51	-96	-80	-37	-56	61	-93	-149	-179	-205	-601	98
TTM Cash Flow to Firm	-5	-15	-19	-35	-66	-64	-24	-47	173	-96	171	-136	-135	-431	232
TTM Free Cash Flow to Firm	-5	-15	-19	-34	-64	-61	-16	-46	185	-84	195	-83	41	-289	254

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	-5.2	-1.96	-7.29	-20.57	-5.18	-7.41	-19.97	-35.01	15.02	-51.72	33.23	-42.01	126.21	-7.22	22.81
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	38.99	- -	- -	- -	- -	- -	41.67
Enterprise Value	20	27	109	540	232	366	256	1,529	2,386	4,043	6,135	3,227	2,611	2,155	4,098
Low Price	3.6	2.5	1.65	5.65	4.35	3.07	1.2	3.01	10.41	19.51	42.44	26.81	23.09	19.07	9.57
EV/Sales	68.24	183.21	375.41	3,082.88	606.89	2,308.62	8.16	94.69	14.13	45.94	44.36	13.27	10.85	606.99	4.94
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	36.35	- -	- -	- -	- -	- -	33.51
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	38.91	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-16.08	-2.4	-1.99	-10.43	-4.22	-4.13	-5.51	-13.72	28.3	-50.2	-51.62	-29.57	-16.95	-5.36	-1,543.6
Price/Earnings High	-26.39	-6.27	-4.78	-22.12	-9.23	-6.14	-16.64	-34.39	50.81	-87.82	-68.99	-51.05	-22.21	-7.96	-2,838.36
Price/Earnings Low	-8.26	-1.32	-1.27	-4.52	-2.71	-2.29	-2.58	-4.62	14.37	-23.24	-31.26	-16.14	-12.07	-3.81	-784.83
Price/Book Value	-0.25	-0.22	-0.82	-3.09	-1.04	-1.13	-0.74	-3.29	-6.31	-8.61	-10.05	-4.27	-2.81	-1.43	-2.84
Price/Book Value Average	-0.44	-0.38	-0.37	-2.72	-1.22	-0.85	-0.44	-1.53	-4.59	-8.43	-11.28	-6.35	-3.39	-1.98	-1.55
Price/Book Value High	-0.73	-0.98	-0.9	-5.77	-2.68	-1.26	-1.32	-3.84	-8.24	-14.74	-15.08	-10.95	-4.44	-2.94	-2.85
Price/Book Value Low	-0.23	-0.21	-0.24	-1.18	-0.79	-0.47	-0.2	-0.52	-2.33	-3.9	-6.83	-3.46	-2.42	-1.41	-0.79
Price/Tangible Book Value	2.58	7.25	6.07	4.2	3.9	6.16	5.3	20.97	11.65	9.72	16.39	8.62	10.41	12.71	9.29
Price/Tangible Book Value Average	4.64	12.6	2.75	3.71	4.57	4.64	3.14	9.77	8.47	9.51	18.4	12.81	12.56	17.61	5.07
Price/Tangible Book Value High	7.62	32.91	6.62	7.86	10.01	6.89	9.47	24.49	15.22	16.63	24.59	22.12	16.46	26.14	9.32
Price/Tangible Book Value Low	2.39	6.91	1.76	1.61	2.94	2.57	1.47	3.29	4.3	4.4	11.14	6.99	8.95	12.52	2.58
Price/Sales	94.45	198.54	470.51	3,961.15	864.88	2,834.05	10.19	99.33	15.67	49.29	46.84	14.4	11.98	653.4	5.56
Price/Sales Average	169.91	345.17	213.3	3,494.45	1,015.08	2,133.65	6.03	46.28	11.4	48.24	52.58	21.41	14.45	905.08	3.04
Price/Sales High	278.87	901.75	512.68	7,410.05	2,222.26	3,169.51	18.21	116.01	20.46	84.39	70.27	36.95	18.94	1,343.56	5.58
Price/Sales Low	87.3	189.44	136.44	1,515.27	653.17	1,183.75	2.82	15.6	5.79	22.33	31.84	11.68	10.29	643.28	1.54
Price/Cash Flow	-5.19	-1.9	-7.18	-19.57	-5.03	-6.96	-13.37	-33.95	15.29	-45.27	37.81	-25.73	-18.74	-5.01	25.69
Price/Cash Flow Average	-9.33	-3.3	-3.25	-17.27	-5.9	-5.24	-7.91	-15.82	11.12	-44.31	42.44	-38.25	-22.61	-6.94	14.02
Price/Cash Flow High	-15.32	-8.63	-7.82	-36.61	-12.92	-7.79	-23.89	-39.66	19.96	-77.51	56.72	-66.03	-29.62	-10.31	25.78
Price/Cash Flow Low	-4.8	-1.81	-2.08	-7.49	-3.8	-2.91	-3.7	-5.33	5.65	-20.51	25.7	-20.87	-16.1	-4.94	7.13
Price/Free Cash Flow Average	-9.35	-3.41	-3.3	-18.15	-6.08	-5.58	-11.82	-16.31	10.92	-50.62	37.31	-62.46	152.28	-10	12.45
Price/Free Cash Flow High	-15.35	-8.91	-7.94	-38.48	-13.32	-8.29	-35.7	-40.89	19.61	-88.55	49.86	-107.84	199.53	-14.85	22.89
Price/Free Cash Flow Low	-4.8	-1.87	-2.11	-7.87	-3.91	-3.09	-5.54	-5.5	5.55	-23.44	22.59	-34.08	108.45	-7.11	6.33
EV/Sales Average	145.84	330.57	149.31	2,739.92	803	1,608.21	5.3	44.52	10.08	46.85	51.43	21.38	14.54	1,028.98	3.41
EV/Sales High	254.8	887.15	448.69	6,655.52	2,010.19	2,644.08	17.48	114.25	19.15	82.99	69.12	36.93	19.02	1,467.46	5.96
EV/Sales Low	63.23	174.84	72.45	760.73	441.09	658.31	2.1	13.84	4.47	20.94	30.69	11.65	10.38	767.18	1.92
EV/EBITDA Average	-4.52	-2.51	-2.01	-9.64	-3.28	-3.33	-5.16	-14.03	25.92	-47.26	-50.52	-30.94	-18.18	-6.27	23.17
EV/EBITDA High	-7.89	-6.74	-6.05	-23.41	-8.2	-5.48	-17	-36	49.24	-83.73	-67.9	-53.44	-23.78	-8.95	40.44
EV/EBITDA Low	-1.96	-1.33	-0.98	-2.68	-1.8	-1.36	-2.04	-4.36	11.5	-21.13	-30.15	-16.86	-12.98	-4.68	13.04
EV/EBIT Average	-4.39	-2.3	-1.86	-9.38	-3.2	-3.2	-4.5	-12.85	27.8	-44.25	-47.72	-29.13	-17.07	-6.08	28.8
EV/EBIT High	-7.68	-6.18	-5.59	-22.79	-8	-5.25	-14.84	-32.97	52.81	-78.39	-64.13	-50.32	-22.33	-8.67	50.27
EV/EBIT Low	-1.9	-1.22	-0.9	-2.61	-1.76	-1.31	-1.78	-3.99	12.33	-19.78	-28.48	-15.88	-12.18	-4.53	16.22
Last Price	3.9	2.62	5.69	14.77	5.76	7.35	4.33	19.17	28.18	43.06	62.43	33.05	26.87	19.37	34.49
High Price	11.5	11.9	6.2	27.63	14.8	8.22	7.74	22.39	36.8	73.72	93.66	84.83	42.48	39.83	34.61
Enterprise Value Average	43	49	43	479	307	255	167	719	1,701	4,122	7,112	5,200	3,499	3,654	2,833
Enterprise Value High	75	130	130	1,165	768	419	549	1,844	3,232	7,303	9,558	8,982	4,579	5,211	4,944
Enterprise Value Low	19	26	21	133	168	104	66	223	755	1,843	4,244	2,834	2,498	2,724	1,595

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	9	14	32	55	60	70	75	89	96	102	104	106	107	124	136
Diluted Weighted Avg Shares	7	11	24	47	57	61	74	84	99	101	104	106	107	120	134
Basic Weighted Avg Shares	7	11	24	47	57	61	74	84	94	101	104	106	107	120	134
Revenue per Share	0.04	0.01	0.01	- -	0.01	- -	0.43	0.19	1.8	0.87	1.33	2.3	2.24	0.03	6.2
EBITDA per Share	-1.33	-1.74	-0.9	-1.06	-1.63	-1.25	-0.44	-0.61	0.7	-0.87	-1.36	-1.59	-1.79	-4.86	0.91
Operating Income per Share	-1.37	-1.89	-0.97	-1.09	-1.67	-1.31	-0.5	-0.67	0.65	-0.92	-1.44	-1.68	-1.91	-5.02	0.74
Basic EPS, GAAP	-0.44	-1.9	-1.3	-1.25	-1.6	-1.34	-0.47	-0.65	0.72	-0.84	-1.36	-1.66	-1.91	-5	-0.01
Basic EPS from Cont Ops	-1.22	-1.99	-1.32	-1.25	-1.6	-1.34	-0.47	-0.65	0.72	-0.84	-1.36	-1.67	-1.95	-5.09	0.23
Diluted EPS, GAAP	-0.44	-1.9	-1.3	-1.25	-1.6	-1.34	-0.47	-0.65	0.69	-0.84	-1.36	-1.66	-1.91	-5	-0.01
Diluted EPS from Cont Ops	-1.22	-1.99	-1.32	-1.25	-1.6	-1.34	-0.47	-0.65	0.69	-0.84	-1.36	-1.67	-1.95	-5.09	0.23
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.75	-1.38	-0.79	-0.75	-1.15	-1.06	-0.32	-0.56	1.84	-0.95	1.65	-1.28	-1.43	-3.86	1.34
Free Cash Flow per Basic Share	-0.75	-1.42	-0.81	-0.79	-1.18	-1.12	-0.43	-0.58	1.72	-1.07	1.42	-1.78	-3.08	-5.05	1.17
Cash & Equivalents per Share	1.13	0.31	1.17	3.28	1.72	1.4	0.89	0.92	2.76	3.13	3.55	3.55	3.76	5.68	6.87
Book Value per Share	-15.85	-12.12	-6.92	-4.79	-5.52	-6.52	-5.85	-5.82	-4.47	-5	-6.21	-7.74	-9.56	-13.57	-12.16
Tangible Book Value per Share	1.51	0.36	0.94	3.52	1.48	1.19	0.82	0.91	2.42	4.43	3.81	3.84	2.58	1.52	3.71

Arrowhead Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)